BEIJING and CLAREMONT, Calif., Feb. 5 /Xinhua-PRNewswire-FirstCall/ -- Kiwa Bio-Tech Products Group Corporation (OTC Bulletin Board: KWBT) reports on a meeting between Kiwa CEO and Board Chairman, Mr. Wei Li, and Dr. Xiao-Dong Huang from the Department of Biology, the University of Waterloo, Canada to discuss the possibility of collaboration in research and development (R&D) of plant growth promoting rhizobacteria (PGPR) base bio-products and biotechnology for agriculture production and environment protection.
Dr. Xiao-Dong Huang works at the University of Waterloo (UW) as the Director of International Collaboration Education Program of China 2+2 and Research Associate Professor of the Department of Biology. The biotechnology research group composed of Dr. Huang, Dr. Glick and Dr. Greenberg has developed several bio-products and bio-techniques that have been successfully applied to the agricultural and environmental industry.
During the meeting, Dr. Huang agreed with Mr. Wei, Li that great
potential exits for collaboration between the UW group and Kiwa on research
and development of PGPR based bio-products and biotechnology. Dr. Huang
presented information about their commercial applications in agriculture
and environment, including successful applications in petroleum and salt
contaminated soil remediation. The results from commercial field
applications have shown their distinct positive effects on petroleum
degradation in oil fields and vegetation recovery from salt impacted soils
in Western Canada. In addition, Dr, Huang has also identified that PGPR
based technology can be used in commercial operations in agricultural
-- Increasing crop tolerance and yield in saline soils,
-- Reducing and degrading agro-chemical residual and pollution, and
-- Increasing effectiveness of chemical fertilizers,
-- Reducing chemical fertilizers and pesticide use, and
-- Increasing yield and improve crop quality.
After discussion, Dr. Huang looked forward to meeting with Pro. Qi Wang, Director of Kiwa-CAU R&D Center and to establishing collaboration relations with Kiwa Corp.
Mr. Wei Li, Chairman of the Board and CEO of the Company, stated, "This was a successful meeting, both parties agreed and are willing to cooperate. Based on the established firm strategic cooperative relations, on agricultural industry penetration and development, with China Agricultural Ministry, China Green Food Association and other institutions, together with the technological support from China Agriculture University, we expect to build a cooperative relation with Dr. Huang's research team to develop and introduce some new bio- tech products with significant commercial value meeting the market requirements in China."
ABOUT KIWA BIO-TECH PRODUCTS GROUP CORPORATION
The Company develops, manufactures, distributes and markets innovative, cost-effective, and environmentally safe bio-technological products for agricultural and natural resources and environmental conservation. The Company has acquired the rights to manufacture and market AF-01 Anti-viral Aerosol Agent for use in preventing (blocking) bird-flu disease in Chinese and international markets. The Company has excellent relations with government authorities in China and has developed several innovative, high margin products, while continuing to grow through internal and external product development. The Company's products are designed to enhance the quality of human life by increasing the value, quality and productivity of crops and decreasing the negative environmental impact of chemicals and other wastes. For more information about the Company, please review documents filed with the SEC (http://www.sec.gov) or visit the Company's website at http://www.kiwabiotech.com.
This press release contains information that constitutes
forward-looking statements made pursuant to the safe harbor provisions of
the Private Securities Litigation Reform Act of 1995. Any such
forward-looking statements involve risk and uncertainties that could cause
actual results to differ materially from any future results described by
the forward-looking statements. Risk factors that could contribute to such
differences include those matters more fully disclosed in the Company's
reports filed with the Securities and Exchange Commission. The
forward-looking information provided herein represents the Company's
estimates as of the date of the press release, and subsequent events and
developments may cause the Company's estimates to change. The Company
specifically disclaims any obligation to update the forward-looking
information in the future. Therefore, this forward-looking information
should not be relied upon as representing the Company's estimates of its
future financial performance as of any date subsequent to the date of this
Kiwa Bio-Tech Products Group Corporation
|SOURCE Kiwa Bio-Tech Products Group Corporation|
Copyright©2008 PR Newswire.
All rights reserved